6.135
2.42%
0.145
Dopo l'orario di chiusura:
6.14
0.005
+0.08%
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-02-26 | 2022-11-27 |
Durata del periodo | 3 mesi | 3 mesi |
Revenues |
21.37%
26.54
|
21.86 |
Cost Of Revenue |
11.14%
17.99
|
16.18 |
Gross Profit |
50.52%
8.548
|
5.679 |
Operating Expenses
|
36.70%
15.08
|
11.03 |
Interest Income/Expense |
33.97%
4.855
|
3.624 |
Benefits Costs and Expenses |
21.68%
37.80
|
31.06 |
Costs And Expenses |
21.68%
37.80
|
31.06 |
Operating Income/Loss |
22.03%
-6.531
|
-5.352 |
Income/Loss From Continuing Operations Before Tax |
22.43%
-11.26
|
-9.197 |
Income Tax Expense/Benefit |
1,650%
0.07
|
0.004 |
Income/Loss From Continuing Operations After Tax |
23.14%
-11.33
|
-9.201 |
Income/Loss From Discontinued Operations, Net Of Tax |
598.39%
-25.18
|
-3.605 |
Net Income/Loss
|
185.08%
-36.51
|
-12.81 |
Preferred Stock Dividends And Other Adjustments |
-
|
- |
Attributable To Noncontrolling Interest |
-
|
- |
Basic Average Shares |
2.26%
30.30
|
29.63 |
Diluted Average Shares |
2.26%
30.30
|
29.63 |
Basic Earnings Per Share |
179.07%
-1.20
|
-0.43 |
Diluted Earnings Per Share |
179.07%
-1.20
|
-0.43 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):